The largest database of trusted experimental protocols

1 2 5 6 tetrahydropyridin 4 yl methylphosphinic acid tpmpa

Manufactured by Bio-Techne
Sourced in United Kingdom

(1,2,5,6-Tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA) is a chemical compound used in research applications. It functions as a GABAA receptor antagonist. This compound is utilized in laboratory studies to investigate the role of GABAA receptors in various biological processes.

Automatically generated - may contain errors

4 protocols using 1 2 5 6 tetrahydropyridin 4 yl methylphosphinic acid tpmpa

1

Pharmacological Modulation of Neuronal Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drugs used included GABA, hexamethonium bromide (both from Sigma Aldrich, Castle Hill, New South Wales, Australia), Bicuculline, [S-(R*,R*)]-[3-[[1-(3,4-Dichlorophenyl)ethyl]amino]-2-hydroxypropyl](cyclohexylmethyl) phosphinic acid (CGP 54626) and (1,2,5,6-Tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA) (all from Tocris Bioscience, Avonmouth Bristol UK). All drugs were diluted in distilled water to make stock solutions and then again in physiological saline to their working concentration on the day of experimentation.
+ Open protocol
+ Expand
2

Synaptic Blockade in Retina Explant

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blocking of various synapses was achieved by bath applying various pharmacological substances dissolved in aCSF, which superfused the explanted retina as described. Gap junctions were blocked with 50 µM MFA (Sigma Aldrich) that was applied for 30 min before the data were recorded. Glutamatergic signaling was blocked using a combination of three compounds: 100 µM 6,7-dinitroquinoxaline-2,3-dione (DNQX; Tocris Bioscience, Bristol, UK) was used to block the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamatergic synapses, 100 µM DL-AP5 (Tocris Bioscience) was used to block the N-methyl-D-aspartate (NMDA) glutamatergic synapses, and 150 µM DL-AP4 (Tocris Bioscience) was used to block the metabotropic (mGluR6) synapses. As an mGluR6 agonist, DL-AP4 did not allow the investigation of synapses downstream of the transfected ON bipolar cells. Gamma-aminobutyric acid (GABA)a and GABAc receptors were antagonized with 20 µM picrotoxin and 50 µM 1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA), respectively (Tocris Bioscience).
+ Open protocol
+ Expand
3

Pharmacological Modulation of Cholinergic Circuits

Check if the same lab product or an alternative is used in the 5 most similar protocols
All drugs were bath applied for at least ten minutes before recordings. The following drug concentrations were used (in μM): 10 Gabazine (Tocris Bioscience, Bristol, UK)50 (link), 75 TPMPA (1,2,5,6-Tetrahydropyridin-4-yl)methylphosphinic acid, Tocris Bioscience)50 (link), 50 L-AP4 (L-(+)-2-Amino-4-phosphonobutyric acid, Tocris Bioscience) and 0.5 strychnine (Sigma-Aldrich)51 (link). Drug solutions were carboxygenated and warmed to ~37°C before application. Pharmacological experiments were exclusively performed in the On and Off ChAT-immunoreactive bands, which are labelled in red fluorescence in ChAT:Cre c Ai9tdTomato crossbred animals.
+ Open protocol
+ Expand
4

Pharmacological Modulation of Cholinergic Circuits

Check if the same lab product or an alternative is used in the 5 most similar protocols
All drugs were bath applied for at least ten minutes before recordings. The following drug concentrations were used (in μM): 10 Gabazine (Tocris Bioscience, Bristol, UK)50 (link), 75 TPMPA (1,2,5,6-Tetrahydropyridin-4-yl)methylphosphinic acid, Tocris Bioscience)50 (link), 50 L-AP4 (L-(+)-2-Amino-4-phosphonobutyric acid, Tocris Bioscience) and 0.5 strychnine (Sigma-Aldrich)51 (link). Drug solutions were carboxygenated and warmed to ~37°C before application. Pharmacological experiments were exclusively performed in the On and Off ChAT-immunoreactive bands, which are labelled in red fluorescence in ChAT:Cre c Ai9tdTomato crossbred animals.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!